BPC-157 and LL-37 Interaction

Q: Can I take BPC-157 with LL-37?

Yes, BPC-157 and LL-37 can generally be taken together. Enhanced wound healing through complementary mechanisms.

Q: Is BPC-157 and LL-37 safe together?

Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.

Q: What are the interactions between BPC-157 and LL-37?

Enhanced wound healing through complementary mechanisms. This assessment has 95% confidence and is based on documented research data.

Q: How should I time BPC-157 and LL-37?

BPC-157 has a half-life of <30 minutes and LL-37 has a half-life of Short (rapid proteolytic degradation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Synergistic

Researched 95% confidence

BPC-157 and LL-37 have a synergistic interaction with 95% confidence. Enhanced wound healing through complementary mechanisms. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity

vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic

View full profile

LL-37

Human Cathelicidin | Antimicrobial Peptide

Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..

Half-life: Short (rapid proteolytic degradation) Typical dose: 0.5-1.6 mg/mL topical gel or 100-150 mcg injectable immune, healing

View full profile

Combined Organ Load

Blood Vessels

low

Frequently Asked Questions

Can I take BPC-157 with LL-37?

Yes, BPC-157 and LL-37 can generally be taken together. Enhanced wound healing through complementary mechanisms.

Is BPC-157 and LL-37 safe together?

Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between BPC-157 and LL-37?

Enhanced wound healing through complementary mechanisms. This assessment has 95% confidence and is based on documented research data.

How should I time BPC-157 and LL-37?

BPC-157 has a half-life of <30 minutes and LL-37 has a half-life of Short (rapid proteolytic degradation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs LL-37

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.